Table 2 Insomnia and quality of sleep among cases and control
From: Sleep quality among psoriasis patients: excluding the immunosuppressive therapy effect
| Â | Cases | Controls | P value | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Mean | SD | Median | Min | Max | Mean | SD | Median | Min | Max | ||
ISI | 9.50 | 6.00 | 8.00 | 0.00 | 27.00 | 3.48 | 4.85 | 1.00 | 0.00 | 19.00 | < 0.001 |
Global PSQl score | 8.16 | 4.06 | 8.00 | 0.00 | 19.00 | 3.25 | 2.68 | 2.00 | 0.00 | 11.00 | < 0.001 |
Subjective sleep quality | 1.14 | 1.15 | 1.00 | 0.00 | 3.00 | 0.35 | 0.62 | 0.00 | 0.00 | 2.00 | < 0.001 |
Sleep latency | 1.27 | 1.15 | 1.00 | 0.00 | 3.00 | 0.98 | 0.86 | 1.00 | 0.00 | 3.00 | 0.135 |
Sleep duration | 0.93 | 1.03 | 1.00 | 0.00 | 3.00 | 0.88 | 0.64 | 1.00 | 0.00 | 3.00 | 0.589 |
Habitual sleep efficiency | 1.01 | 1.19 | 0.50 | 0.00 | 3.00 | 0.15 | 0.36 | 0.00 | 0.00 | 1.00 | < 0.001 |
Sleep disturbance | 1.41 | 0.71 | 1.00 | 0.00 | 3.00 | 0.75 | 0.67 | 1.00 | 0.00 | 2.00 | < 0.001 |
Use of sleeping medication | 1.38 | 0.91 | 1.00 | 0.00 | 3.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | < 0.001 |
Daytime dysfunction | 1.01 | 1.03 | 1.00 | 0.00 | 4.00 | 0.18 | 0.44 | 0.00 | 0.00 | 2.00 | < 0.001 |